This present invention relates to a new and improved reductive amination
process for the preparation of 3-azabicyclo[3.1.0]hexane derivatives and
pharmaceutical compositions comprising such derivatives. The invention
particularly relates to using such derivatives to treat certain disorders
and conditions, including, for example, irritable bowel syndrome, drug
addiction or dependency, alcohol addiction or dependency, depression, and
eating disorders.